Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 530.15% and ...
Some people are taking tiny amounts of weight loss medications, hoping to drop pounds while avoiding side effects. Does it ...
The weight loss revolution is in full swing, with the number of patients receiving Wegovy (NVO) having doubled while those ...
With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more ...
Viking has a strong GLP-1 agonist candidate that may win approval by 2027, and makes the company a target for M&A. Read the ...
A doctor, bariatric surgeon and professor say that treatments other than weight-loss drugs are needed to fix the obesity ...
The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs' c ...
MIT researchers have developed a type of gastric balloon that can be inflated and deflated in a person's stomach to mimic the ...
Wall Street is chewing over data on Amgen’s weight loss injection, MariTde. Meanwhile, GE HealthCare will acquire a Japanese ...
A proposal from the Biden administration to provide coverage of weight loss drugs through Medicaid and Medicare may cost more ...
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.
As 'ballet body' beauty standards return, skin care that tackles elasticity and volume restoration will be in demand, with ...